19

What are the best strategies for using participant incentives (e.g. monetary or non-monetary) and how should they be implemented (e.g. when should they be provided) when collecting information from participants in clinical trials?

  • “Financial incentives will be viewed suspiciously if high… and not very incentivising if low. On the other hand, participants welcome personal touches as the offer of a lift to the clinic, or a small gift token, or even just a profuse thank you for their help.” (Frontline staff or other staff involved or invested in trial retention (e.g. Research Nurse, Trial Manager, regulatory or oversight role such as Sponsor or Research Director))
  • “Would a donation of a pre-specified amount of money to a charity of the participant’s choice on completion of the clinical trial improve retention?” (Patient or public member involved in a trial (as a participant or parent/carer of a participant, or as a contributor to design/delivery of trial))
TMRN IconTMRN Icon